XOMA Royalty Corporation Depositary Shs Repr 1/1000th 8.375% Cum Conv Perp Red Pfd Rg Shs Series B XOMAO 深 沪
已收盘 07-02 16:00:00 美东时间
24.97
+0.028
+0.11%
华盛通- 最 高25.14
- 今 开25.14
- 成交量 1.33万股
- 最 低 24.92
- 昨 收 24.9416
- 总市值 4395.97万
- 52周最高 25.8766
- 市盈率 静 --
- 换手率 0.75%
- 52周最低 23.0763
- 委 比 31.12%
- 总股本 176.05万
- 历史最高 25.8766
- 量 比 2.78
- 振 幅 0.88%
- 历史最低 13.0229
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ligand特许权资产组合规模翻倍 超200项资产令LGND关注度大幅提升
核心事件：Ligand拟斥资约7.39亿美元收购XOMA旗下特许权资产平台，交易预计2026年第三季度完成交割，推动公司向特许权复利增值模式转型。 关键数据：交...
07-01 09:56
Ligand Announces Closing of Convertible Senior Notes Offering
Ligand Pharmaceuticals completed a $700 million convertible senior notes offering, with net proceeds of $678.2 million. $72.9 million was used for convertible note hedge transactions, and $60 million repurchased 228,859 shares of common stock at $262.17 per share. Remaining funds will be used for general corporate purposes, including potential acquisitions.
06-25 20:01
XOMA Details Merger Timeline and Preferred Share Redemption
An update from XOMA Royalty Corporation ( ($XOMA) ) is now available. On June 1...
06-13 07:53
XOMA Preferred Shares Series A declares $0.539 dividend
XOMA Preferred Shares Series A (XOMAP) declares $0.539/share quarterly dividend, in line with previous. Forward yield 8.47% Payable July 15; for shareholders of record July 2; ex-div July 2. See XOMAP...
06-13 04:14
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
XOMA Royalty Corporation announced that its Board of Directors has authorized cash dividends for holders of its Series A and Series B Preferred Stock, with dividends of $0.53906 per share for Series A and $0.52344 per depositary share for Series B. The Preferred Stock will be redeemed on July 14, 2026, at $25.00 per share or depositary share. Dividends will be paid on July 15, 2026, to holders of record as of July 2, 2026. The redemption is part ...
06-12 20:05
XOMA Royalty amends merger agreement with Ligand Pharmaceuticals
An announcement from XOMA Royalty Corporation ( ($XOMA) ) is now available. On ...
05-18 22:08
Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
AnaptysBio appoints Christopher Murphy as CFO and Owen Hughes to its Board, enhancing expertise in finance, business development, and royalty management. Murphy brings extensive experience in corporate strategy and investment banking, while Hughes has over two decades of leadership in royalty management and corporate development. AnaptysBio focuses on managing financial collaborations for Jemperli with GSK and imsidolimab with Vanda, aiming to pr...
05-11 13:15
Are SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
05-09 05:57
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
04-27 23:24
Suja Life launches IPO roadshow, targets $21–$24 per share
Suja Life (SUJA) on Monday said it has begun the roadshow for its initial public offering of 8,888,889 Class A shares, with a price range of $21 to $24 per share. Of the total shares, 8,688,170 are be...
04-27 19:40
